Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Beta-L-FD4C compared to lamivudine in woodchuck model of chronic HBV infection

Nov. 16, 1999

FR-167653 examined in rat model of hepatic ischemia/reperfusion injury

Nov. 15, 1999

rhIL-10 reduces liver injury, normalizes serum ALT in HCV patients failing interferon

Nov. 15, 1999

CDP-571 is effective in Crohn's disease: phase IIb study results announced

Nov. 15, 1999

AASLD presentations support feasibility of ribozyme therapy in HCV

Nov. 12, 1999

Phase II data support further study of VX-497 for hepatitis C

Nov. 12, 1999

Preliminary phase II results promising for Maxamine in HCV

Nov. 11, 1999

Dainippon discloses new compounds useful for the treatment or prophylaxis of liver disease

Nov. 10, 1999

Anti-H. pylori compound isolated from Acinetobacter at Takeda laboratories

Nov. 10, 1999

Incara begins clinical program for IBD, explores strategic alternatives

Nov. 9, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...